InVentiv launches doc network for late-stage trials

CRO inVentiv Health ($VTIV) has launched a crowdsourced physician network, signing up doctors interested in late-stage research to speed the recruitment process for trial sponsors.

Housed at InVentivDocNet.com, the platform will enroll tens of thousands of doctors throughout the year, inVentiv said, pooling information on expertise and schedule and exposing them to a list of late-stage studies, allowing sponsors and clinicians to meet on their own terms.

For sponsors, the network will eliminate much of the time-consuming and costly guesswork in physician recruitment, inVentiv Vice President Jeff Trotter said, at the same time giving doctors a change to contribute to better health outcomes.

"We believe physicians will find this a valuable new channel for accessing real-world research opportunities," company Vice President Jeff Trotter said in a statement. "The inVentiv Physician Network welcomes virtually any clinician who seeks to participate in observational research, including patient registries, safety surveillance programs, post-approval safety studies, and other noninterventional and quality-of-life studies."

The new offering is the CRO's latest effort to use technology to speed up clinical trials. InVentiv uses electronic informed consent technology from Mytrus, a clinical software developer in which it bought an equity stake in March. And in June, inVentiv partnered with PatientsLikeMe, allowing that site's more than 200,000 members to view and apply for client trials that apply to their conditions.

- read the announcement

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.